Search research articles
Contact Us
Filters
Showing results (321-330 of 403) with videos related to
Page
of 41
Sort By:
Current Problems in Cardiology
|
December 4, 2022
Diversity in U.S. Cardiovascular Trainees and Leadership Where we are and What the Future Holds
Christoph W Sossou, Sadaf Fakhra, Kavita Batra, et al.
Angiology
|
February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial
Zhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
Journal of the American College of Cardiology
|
June 12, 2003
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry
Gregg W Stone, E Magnus Ohman, Michael F Miller, et al.
Journal of the American College of Cardiology
|
October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes
Marc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
The Laryngoscope
|
April 12, 2018
Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery
Evangelia Katsoulakis, Jonathan E Leeman, Benjamin H Lok, et al.
Circulation. Cardiovascular Interventions
|
June 14, 2018
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
Jean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
European Heart Journal
|
June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis
Sabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
The American Journal of Cardiology
|
April 24, 2017
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease
Aakash Garg, Sunil V Rao, Sahil Agrawal, et al.
Journal of the American College of Cardiology
|
April 23, 2013
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51
C Michael Gibson, Anjan K Chakrabarti, Jessica Mega, et al.
Journal of the American College of Cardiology
|
July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial
Elizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
Page
of 41
Search research articles
Search
Showing results (321-330 of 403) with videos related to
Sort By:
Page
of 41
Current Problems in Cardiology
|
December 4, 2022
Diversity in U.S. Cardiovascular Trainees and Leadership Where we are and What the Future Holds
Christoph W Sossou, Sadaf Fakhra, Kavita Batra, et al.
Angiology
|
February 11, 2016
Intravenous Enoxaparin Versus Unfractionated Heparin in Elderly Patients Undergoing Primary Percutaneous Coronary Intervention: An Analysis of the Randomized ATOLL Trial
Zhenyu Liu, Johanne Silvain, Mathieu Kerneis, et al.
Journal of the American College of Cardiology
|
June 12, 2003
Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry
Gregg W Stone, E Magnus Ohman, Michael F Miller, et al.
Journal of the American College of Cardiology
|
October 3, 2006
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes
Marc Cohen, Kenneth W Mahaffey, Karen Pieper, et al.
The Laryngoscope
|
April 12, 2018
Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery
Evangelia Katsoulakis, Jonathan E Leeman, Benjamin H Lok, et al.
Circulation. Cardiovascular Interventions
|
June 14, 2018
Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors: Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
Jean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
European Heart Journal
|
June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis
Sabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
The American Journal of Cardiology
|
April 24, 2017
Meta-Analysis of Randomized Controlled Trials of Percutaneous Coronary Intervention With Drug-Eluting Stents Versus Coronary Artery Bypass Grafting in Left Main Coronary Artery Disease
Aakash Garg, Sunil V Rao, Sahil Agrawal, et al.
Journal of the American College of Cardiology
|
April 23, 2013
Reduction of stent thrombosis in patients with acute coronary syndromes treated with rivaroxaban in ATLAS-ACS 2 TIMI 51
C Michael Gibson, Anjan K Chakrabarti, Jessica Mega, et al.
Journal of the American College of Cardiology
|
July 29, 2017
Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Results From the PEGASUS-TIMI 54 Trial
Elizabeth A Magnuson, Haiyan Li, Kaijun Wang, et al.
Page
of 41